T
0.520
-0.03 (-5.11%)
| 前收盘价格 | 0.548 |
| 收盘价格 | 0.588 |
| 成交量 | 982,263 |
| 平均成交量 (3个月) | 486,011 |
| 市值 | 9,089,600 |
| 市盈率 (P/E TTM) | 0.018 |
| 价格/销量 (P/S) | 0.800 |
| 52周波幅 | |
| 利润日期 | 13 Feb 2025 - 17 Feb 2025 |
| 营业利益率 (TTM) | -490.52% |
| 稀释每股收益 (EPS TTM) | 29.70 |
| 季度收入增长率 (YOY) | -0.60% |
| 流动比率 (MRQ) | 0.600 |
| 营业现金流 (OCF TTM) | -43.73 M |
| 杠杆自由现金流 (LFCF TTM) | -31.85 M |
| 资产报酬率 (ROA TTM) | -90.46% |
市场趋势
| 短期 | 中期 | ||
| 行业 | Diagnostics & Research (US) | 混合的 | 混合的 |
| Diagnostics & Research (全球的) | 混合的 | 混合的 | |
| 股票 | T2 Biosystems, Inc. | 混合的 | 看跌 |
AIStockmoo 评分
0.3
| 分析师共识 | NA |
| 内部交易活动 | NA |
| 价格波动 | 0.5 |
| 技术平均移动指标 | 2.5 |
| 技术振荡指标 | -2.0 |
| 平均 | 0.33 |
|
T2 Biosystems Inc is a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes. It is dedicated to improving patient care and reducing the cost of care by helping clinicians effectively treat patients faster than ever before. The company’s products include the T2Dx Instrument, the T2Bacteria Panel, the T2Candida Panel, the T2Resistance Panel, and the T2Biothreat Panel, and are powered by the proprietary T2 Magnetic Resonance technology. |
|
| 部门 | Healthcare |
| 行业 | Diagnostics & Research |
| 投资方式 | Small Value |
| 内部持股比例 | 4.45% |
| 机构持股比例 | 74.65% |
该时间范围内无数据。
该时间范围内无数据。
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合